Werewolf Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Werewolf Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Werewolf Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Werewolf Therapeutics by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $319 | 83 | 3.86 |
2023-09-30 | $1.6k | 748 | 2.14 |
2023-06-30 | $2.3k | 748 | 3.05 |
2023-03-31 | $2.0k | 748 | 2.67 |
2022-12-31 | $2.0k | 748 | 2.67 |
2022-06-30 | $14k | 3.7k | 3.67 |
2022-03-31 | $68k | 16k | 4.36 |
2021-12-31 | $334k | 28k | 11.90 |